All Pharma News
Avicanna Announces Results of Annual General Meeting & Provides Corporate Update

Avicanna Announces Results of Annual General Meeting & Provides Corporate Update
GLOBENEWSWIRE
10 Jul 2024
Share Share
Avicanna Announces USPTO Patent Issuance For SEDDS Technology

Avicanna Announces USPTO Patent Issuance For SEDDS Technology
GLOBENEWSWIRE
19 Jun 2024
Share Share
Avicanna Announces General Meeting

Avicanna Announces General Meeting
GLOBENEWSWIRE
19 Jun 2024
Share Share
Avicanna To Present At Life Science Investor Forum June 20, 2024

Avicanna To Present At Life Science Investor Forum June 20, 2024
GLOBENEWSWIRE
18 Jun 2024
Share Share
Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter

Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter
GLOBENEWSWIRE
14 May 2024
Share Share
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa

Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
GLOBENEWSWIRE
13 May 2024
Share Share
Avicanna Announces Closing of Non-brokered Private Placement

Avicanna Announces Closing of Non-brokered Private Placement
GLOBENEWSWIRE
18 Apr 2024
Share Share
Avicanna Completes Topical Gel Observational Study

Avicanna Completes Topical Gel Observational Study
GLOBENEWSWIRE
10 Apr 2024
Share Share
Avicanna Reports Full Year 2023 Audited Financial Results

Avicanna Reports Full Year 2023 Audited Financial Results
GLOBENEWSWIRE
02 Apr 2024
Share Share
Avicanna Announces the Canadian Launch of 10% CBD Proprietary Formulation

Avicanna Announces the Canadian Launch of 10% CBD Proprietary Formulation
GLOBENEWSWIRE
27 Mar 2024
Share Share